Metropolitan Life Insurance CO Theravance Biopharma, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$8.22 - $11.59 $5,745 - $8,101	-699 Reduced 20.13%	2,773 $24,000
Q2 2023 Aug 10, 2023	BUY	$10.16 - $11.92 $35,275 - $41,386	3,472 New	3,472 $35,000
Q4 2022 Jun 14, 2023	BUY	$9.65 - $11.34 $39,352 - $46,244	4,078 New	4,078 $45.8 Million
Q3 2022 Jun 14, 2023	BUY	$8.39 - $10.22 $34,214 - $41,677	4,078 New	4,078 $41.4 Million
Q2 2022 Jun 20, 2023	BUY	$8.41 - $10.34 $34,295 - $42,166	4,078 New	4,078 $36.9 Million
Q1 2022 Jun 20, 2023	BUY	$8.33 - $12.96 $33,969 - $52,850	4,078 New	4,078 $39 Million
Q4 2021 Jun 21, 2023	BUY	$7.42 - $11.05 $91,273 - $135,926	12,301 New	12,301 $136 Million
Q3 2021 Jun 21, 2023	BUY	$6.77 - $14.41 $50,991 - $108,536	7,532 New	7,532 $55.7 Million
Q1 2021 Jun 26, 2023	BUY	$16.57 - $21.08 $220,596 - $280,638	13,313 New	13,313 $272 Million
Q4 2020 Jun 22, 2023	BUY	$14.89 - $20.16 $212,227 - $287,340	14,253 New	14,253 $253 Million
Q3 2020 Jun 26, 2023	BUY	$14.79 - $22.49 $210,801 - $320,549	14,253 New	14,253 $211 Million
Q2 2020 Jun 26, 2023	BUY	$20.64 - $30.69 $294,181 - $437,424	14,253 New	14,253 $299 Million
Q1 2020 Jul 12, 2023	BUY	$17.84 - $31.21 $254,273 - $444,836	14,253 New	14,253 $329 Million
Q4 2019 Jul 12, 2023	BUY	$16.12 - $25.89 $224,084 - $359,896	13,901 New	13,901 $360 Million
Q3 2019 Jul 12, 2023	BUY	$16.51 - $23.78 $241,277 - $347,520	14,614 New	14,614 $285 Million
Q2 2019 Jul 12, 2023	BUY	$15.6 - $25.15 $227,978 - $367,542	14,614 New	14,614 $239 Million
Q1 2019 Jul 13, 2023	BUY	$22.57 - $28.15 $329,837 - $411,384	14,614 New	14,614 $331 Million
Q4 2018 Jul 13, 2023	BUY	$22.52 - $35.07 $329,107 - $512,512	14,614 New	14,614 $374 Million
Q3 2018 Jul 13, 2023	BUY	$22.83 - $32.67 $320,122 - $458,098	14,022 New	14,022 $458 Million

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

Madison Avenue Partners, LP New York, NY

9.51M
Shares

$91.2 Million
9.44% of portfolio
Weiss Asset Management LP Boston, MA

7.46M
Shares

$71.5 Million
1.94% of portfolio
Newtyn Management, LLC New York, NY

4.5M
Shares

$43.1 Million
6.4% of portfolio
Black Rock Inc. New York, NY

3.78M
Shares

$36.3 Million
0.0% of portfolio
Irenic Capital Management LP New York, NY

2.76M
Shares

$26.5 Million
1.95% of portfolio

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account